Stay updated on CVL-865 Adjunctive Therapy in Focal Seizures Clinical Trial
Sign up to get notified when there's something new on the CVL-865 Adjunctive Therapy in Focal Seizures Clinical Trial page.

Latest updates to the CVL-865 Adjunctive Therapy in Focal Seizures Clinical Trial page
- Check7 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference0.7%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe webpage has been updated to reflect a new clinical trial involving CVL-865, including detailed information about the treatment periods, dosing, and the study's objectives. Notably, AbbVie has replaced Cerevel Therapeutics as the sponsor, and the results reporting dates have been updated.SummaryDifference42%
- Check43 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check64 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check71 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to CVL-865 Adjunctive Therapy in Focal Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-865 Adjunctive Therapy in Focal Seizures Clinical Trial page.